Literature DB >> 18580851

Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level.

Mira Katan1, Nils Morgenthaler, Isabelle Widmer, Jardena J Puder, Caroline König, Beat Müller, Mirjam Christ-Crain.   

Abstract

BACKGROUND: During stress, vasopressin is a potent synergistic factor of CRH as a hypothalamic stimulator of the HPA axis. The measurements of CRH and vasopressin levels are cumbersome because of their instability and short half-life. Copeptin is a more stable peptide stoichiometrically released from the same precursor molecule. The aim of our study was to compare copeptin and cortisol levels in different stress situations.
METHODS: Three groups of patients with increasing stress levels were investigated: a) healthy controls without apparent stress (n=20), b) hospitalized medical patients with moderate stress (n=25) and c) surgical patients 30 minutes after extubation, with maximal stress (n=29). In all patients we assessed cortisol and copeptin levels. Copeptin levels were measured with a new sandwich immunoassay.
RESULTS: Cortisol levels in controls were (median, IQ range, 486 [397-588] nmol/L), not significantly different as compared to medical patients (438 [371-612] nmol/L, p=0.69). Cortisol levels in surgical patients after extubation were higher (744 [645-1062] nmol/L p<0.01 vs controls and medical patients). Copeptin levels in controls were 4.3 [3.2-5.5] pmol/L, which was lower as compared to medical patients (17.5 [6.4-24.1], p<0.001) and surgical patients after extubation (67.5 [37.8-110.0] pmol/L, p<0.001). The correlation between copeptin levels and cortisol was r=0.46, p<0.001.
CONCLUSION: Copeptin is a novel marker of the individual stress level. It more subtly mirrors moderate stress as compared to cortisol values.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18580851

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  55 in total

Review 1.  Copeptin in the differential diagnosis of hypotonic polyuria.

Authors:  M Christ-Crain; W K Fenske
Journal:  J Endocrinol Invest       Date:  2019-07-31       Impact factor: 4.256

Review 2.  Neuroendocrine drivers of risk and resilience: The influence of metabolism & mitochondria.

Authors:  Susie Turkson; Alix Kloster; Peter J Hamilton; Gretchen N Neigh
Journal:  Front Neuroendocrinol       Date:  2019-07-06       Impact factor: 8.606

Review 3.  Copeptin as a biomarker for prediction of prognosis of acute ischemic stroke and transient ischemic attack: a meta-analysis.

Authors:  Qian Xu; Yunfan Tian; Hao Peng; Hongmei Li
Journal:  Hypertens Res       Date:  2016-12-01       Impact factor: 3.872

4.  Serum Copeptin Predicts Severity and Recurrent Stroke in Ischemic Stroke Patients.

Authors:  Wan-Zhong Tang; Xiao-Bo Wang; Huan-Ting Li; Mei Dong; Xiang Ji
Journal:  Neurotox Res       Date:  2017-05-30       Impact factor: 3.911

5.  [Essential cardiac biomarkers in myocardial infarction and heart failure].

Authors:  M Mueller; E Giannitsis; H A Katus
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

6.  Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage.

Authors:  Christian Zweifel; Mira Katan; Philipp Schuetz; Martin Siegemund; Nils G Morgenthaler; Adrian Merlo; Beat Mueller; Mirjam Christ-Crain
Journal:  BMC Neurol       Date:  2010-05-26       Impact factor: 2.474

7.  Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes.

Authors:  Dariush Afzali; Michael Erren; Hermann-Joseph Pavenstädt; Jörn Ole Vollert; Sabine Hertel; Johannes Waltenberger; Holger Reinecke; Pia Lebiedz
Journal:  Clin Res Cardiol       Date:  2013-05-23       Impact factor: 5.460

8.  Plasma copeptin levels in Chinese patients with acute ischemic stroke: a preliminary study.

Authors:  Xiang Dong; Ding-Bo Tao; Ying-Xin Wang; Hong Cao; You-Song Xu; Qiu-Yan Wang
Journal:  Neurol Sci       Date:  2013-01-25       Impact factor: 3.307

9.  Serum copeptin as a new biomarker in the early diagnosis of decline in renal function of type 2 diabetes mellitus patients.

Authors:  Wen Hu; Yao-Jun Ni; Li Ma; Hai-Rong Hao; Liang Chen; Wei-Nan Yu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

10.  Association of HPA axis hormones with copeptin after psychological stress differs by sex.

Authors:  Elias K Spanakis; Gary S Wand; Nan Ji; Sherita Hill Golden
Journal:  Psychoneuroendocrinology       Date:  2015-10-17       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.